Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7159 p144-145
4 August 2001

This article
Reprint
Photocopy


Research & Development News summary


New drugs suppress menstruation safely

Two new antiprogestogens have been found to suppress menstruation safely in animal studies. Antiprogestogens block progesterone action by binding to the progesterone receptor. The two new anti-progestogens, ZK137316 and ZK230211, are new generation antiprogestogens that have increased potency and reduced antiglucocorticoid activity.

Dr Robert Brenner, Oregon Regional Primate Research Centre, United States, and colleagues studied the effects of the two antiprogestogens in monkeys. ZK137316 was found to allow ovulation but block menstruation and ZK230211 to block both ovulation and menstruation. Neither drug suppressed circulating estradiol concentrations below normal follicular phase concentrations, suggesting that it is unlikely that they would be associated with symptoms of oestrogen deprivation, the researchers say. Also, when synthetic oestrogens are normally given, synthetic progesterones are needed in addition to prevent the unopposed actions of oestrogens on the endometrium. However, this may not be needed with the new antiprogesterones because they have endometrial antiproliferative effects, the researchers say.

In a press statement, Dr Bremner emphasised that the drugs were not solely important for lifestyle choice but also had potential to bring relief to women with endometriosis and painful and excessive monthly bleeding. “It is possible to use the oral contraceptive pill without the pill-free interval for this purpose, but not all women can tolerate the pill,” he added (Human Reproduction 2001;16:1562).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal